-
multidisciplinary field, and openness to learning new things. The PhD candidate needs to be proficient in spoken and written English and has a Master’s degree. We are offering a modern research environment and
-
will recover fibres, upcycle fines into new low-carbon constituents, and enable structural reuse. The project comprises 11 partners across the globe, including partners from Europe, Canada and Japan PhD
-
into new low-carbon constituents, and enable structural reuse. The project comprises 11 partners across the globe, including partners from Europe, Canada and Japan Your tasks The tasks of the PhD at ETHZ and
-
to novel personalized strategies of particles de-sign for drug delivery, imaging or diagnosis. This PhD project will develop stimuli-responsive nanozyme coatings for personalized medical implants. Nanozymes
-
, imaging or diagnosis. This PhD project will develop stimuli-responsive nanozyme coatings for personalized medical implants. Nanozymes are nanomaterials capable of mimicking the catalytic activity of natural
-
fluency in English (both written and oral) are mandatory Our offer A project duration of 3 years is envisaged to carry out the above research tasks in the form of a PhD project. The candidate will perform
-
). This doctoral network of 12 PhD candidates aims at exploring the ear-nose-throat area from a microrobotics perspective. Thanks to active matter and small scale microrobotics engineering, three specific goals
-
) This project takes place within the Marie Curie Doctoral Network on Soft Active Matter Microrobots for Medicine (SAM3). This doctoral network of 12 PhD candidates aims at exploring the ear-nose-throat area from
-
, selectively forgetting, and adapting their behavior through experience, all while retaining commercial-grade mechanical properties. In this PhD project, you will synthesize and characterize semi-crystalline
-
focus lies on nucleic-acid delivery for next-generation therapeutics. This PhD project aims to develop lipid-based nanoparticles for the controlled co-delivery of multiple genetic cargos to cancer cells